Linking epigenetics to lipid metabolism: Focus on histone deacetylases

References

• Alaynick WA. 2008. Nuclear receptors, mitochondria and lipid metabolism. Mitochondrion 8:329–337.
   PubMed Web of Science ®Google Scholar
• Antos CL, McKinsey TA, Dreitz M, Hollingsworth LM, Zhang CL, Schreiber K, 2003. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J Biol Chem 278:28930–28937.
   PubMed Web of Science ®Google Scholar
• Boulias K, Talianidis I. 2004. Functional role of G9a-induced histone methylation in small heterodimer partner-mediated transcriptional repression. Nucleic Acids Res 32:6096–6103.
   PubMedGoogle Scholar
• Cao DJ, Wang ZV, Battiprolu PK, Jiang N, Morales CR, Kong Y, 2011. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci USA 108:4123–4128.
   PubMed Web of Science ®Google Scholar
• Cantó C, Auwerx J. 2010. AMP-activated protein kinase and its downstream transcriptional pathways. Cell Mol Life Sci 67:3407–3423.
   PubMed Web of Science ®Google Scholar
• Choi JH, Banks AS, Estall JL, Kajimura S, Bostrom P, Laznik D, 2010. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5. Nature 466:451–456.
   PubMed Web of Science ®Google Scholar
• Czubryt MP, McAnally J, Fishman GI, Olson EN. 2003. Regulation of peroxisome proliferator activated receptor gamma coactivator 1α (PGC-1α) and mitochondrial function by MEF2 and HDAC5. Proc Natl Acad Sci USA 100:1711–1716.
   PubMed Web of Science ®Google Scholar
• Dawson MA, Kouzarides T. 2012. Cancer Epigenetics: From mechanism to therapy. Cell 150:12–27.
   PubMed Web of Science ®Google Scholar
• De Fabiani E, Mitro N, Anzulovich AC, Pinelli A, Galli G, Crestani M. 2001. The negative effects of bile acids and tumor necrosis factor-α on the transcription of cholesterol 7α-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: A novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. J Biol Chem 276:30708–30716.
   PubMed Web of Science ®Google Scholar
• De Fabiani E, Mitro N, Gilardi F, Caruso D, Galli G, Crestani M. 2003. Coordinated control of cholesterol catabolism to bile acids and of gluconeogenesis via a novel mechanism of transcription regulation linked to the fasted-to-fed cycle. J Biol Chem 278:39124–39132.
   PubMed Web of Science ®Google Scholar
• Dompierre JP, Godin JD, Charrin BC, Cordelieres FP, King SJ, Humbert S, 2007. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J Neurosci 27:3571–3583.
   PubMed Web of Science ®Google Scholar
• Donohoe DR, Garge N, Zhang X, Sun W, O'Connell TM, Bunger MK, 2011. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 13:517–526.
   PubMed Web of Science ®Google Scholar
• Evans RM, Barish GD, Wang YX. 2004. PPARs and the complex journey to obesity. Nat Med 10:355–361.
   PubMed Web of Science ®Google Scholar
• Fang S, Miao J, Xiang L, Ponugoti B, Treuter E, Kemper JK. 2007. Coordinated recruitment of histone methyltransferase G9a and other chromatin-modifying enzymes in SHP-mediated regulation of hepatic bile acid metabolism. Mol Cell Biol 27:1407–1424.
   PubMedGoogle Scholar
• Feng D, Liu T, Sun Z, Bugge A, Mullican SE, Alenghat T, 2011. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 331:1315–1319.
   PubMed Web of Science ®Google Scholar
• Finkel T, Deng CX, Mostoslavsky R. 2009. Recent progress in the biology and physiology of sirtuins. Nature 460:587–591.
   PubMed Web of Science ®Google Scholar
• Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, 2009. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58:1509–1517.
   PubMed Web of Science ®Google Scholar
• Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, 2000. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6:517–526.
   PubMed Web of Science ®Google Scholar
• Gray SG, Ekstrom TJ. 2001. The human histone deacetylase family. Exp Cell Res 262:75–83.
   PubMed Web of Science ®Google Scholar
• Guarente L. 2006. Sirtuins as potential targets for metabolic syndrome. Nature 444:868–874.
   PubMed Web of Science ®Google Scholar
• Gupta MP, Samant SA, Smith SH, Shroff SG. 2008. HDAC4 and PCAF bind to cardiac sarcomeres and play a role in regulating myofilament contractile activity. J Biol Chem 283:10135–10146.
   PubMed Web of Science ®Google Scholar
• Haberland M, Montgomery RL, Olson EN. 2009. The many roles of histone deacetylases in development and physiology: Implications for disease and therapy. Nat Rev Genet 10:32–42.
   PubMed Web of Science ®Google Scholar
• Haeusler RA, Kaestner KH, Accili D. 2010. FoxOs function synergistically to promote glucose production. J Biol Chem 285:35245–35248.
   PubMed Web of Science ®Google Scholar
• Handschin C, Spiegelman BM. 2006. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev 27:728–735.
   PubMed Web of Science ®Google Scholar
• Imai T, Takakuwa R, Marchand S, Dentz E, Bornert JM, Messaddeq N, 2004. Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. Proc Natl Acad Sci USA 101:4543–4547.
   PubMed Web of Science ®Google Scholar
• Kemper JK, Kim H, Miao J, Bhalla S, Bae Y. 2004. Role of an mSin3A-Swi/Snf chromatin remodeling complex in the feedback repression of bile acid biosynthesis by SHP. Mol Cell Biol 24:7707–7719.
   PubMedGoogle Scholar
• Kerr TA, Saeki S, Schneider M, Schaefer K, Berdy S, Redder T, 2002. Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Dev Cell 2:713–720.
   PubMed Web of Science ®Google Scholar
• Knutson SK, Chyla BJ, Amann JM, Bhaskara S, Huppert SS, Hiebert SW. 2008. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J 27:1017–1028.
   PubMed Web of Science ®Google Scholar
• Lahm A, Paolini C, Pallaoro M, Nardi MC, Jones P, Neddermann P, 2004. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc Natl Acad Sci USA 104:17335–17340.
   Google Scholar
• Li G, Jiang H, Chang M, Xie H, Hu L. 2011. HDAC6 α-tubulin deacetylase: A potential therapeutic target in neurodegenerative diseases. J Neurol Sci 304:1–8.
   PubMed Web of Science ®Google Scholar
• Li P, Fan W, Xu J, Lu M, Yamamoto H, Auwerx J, 2011. Adipocyte NCoR knockout decreases PPARg phosphorylation and enhances PPARγ activity and insulin sensitivity. Cell 147:815–826.
   PubMed Web of Science ®Google Scholar
• Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, 2002. Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres. Nature 418:797–801.
   PubMed Web of Science ®Google Scholar
• López-Rodas G, Brosch G, Georgieva EI, Sendra R, Franco L, Loidl P. 1993. Histone deacetylase. A key enzyme for the binding of regulatory proteins to chromatin. FEBS Lett 317:175–180.
   PubMed Web of Science ®Google Scholar
• Lu J, McKinsey TA, Nicol RL, Olson EN. 2000. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci USA 97:4070–4075.
   PubMed Web of Science ®Google Scholar
• Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, 2000. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6:507–515.
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Pocai A, Rossetti L, Depinho RA, Accili D. 2007. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab 6:208–216.
   PubMed Web of Science ®Google Scholar
• McGee SL, van Denderen BJ, Howlett KF, Mollica J, Schertzer JD, Kemp BE, 2008. AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes 57:860–867.
   PubMed Web of Science ®Google Scholar
• McKinsey TA. 2012. Therapeutic potential for HDAC inhibitors in the heart. Annu Rev Pharmacol Toxicol 10:303–319.
   Google Scholar
• McKinsey TA, Zhang CL, Olson EN. 2001. Identification of a signal-responsive nuclear export sequence in class II histone deacetylases. Mol Cell Biol 21:6312–6321.
   PubMed Web of Science ®Google Scholar
• McKinsey TA, Zhang CL, Lu J, Olson EN. 2000. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408:106–111.
   PubMed Web of Science ®Google Scholar
• Mihaylova MM, Vasquez DS, Ravnskjaer K, Denechaud PD, Yu RT, Alvarez JG, 2011. Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell 145:607–621.
   PubMed Web of Science ®Google Scholar
• Miremadi A, Oestergaard MZ, Pharoah PD, Caldas C. 2007. Cancer genetics of epigenetic genes. Hum Mol Genet 16:28–49.
   PubMed Web of Science ®Google Scholar
• Mitro N, Godio C, De Fabiani E, Scotti E, Galmozzi A, Gilardi F, 2007. Insights in the regulation of cholesterol 7α-hydroxylase gene reveal a target for modulating bile acid synthesis. Hepatology 46:885–897.
   Google Scholar
• Nerup J, Pociot F. 2001. A genome wide scan for type 1-diabetes susceptibility in Scandinavian families: Identification of new loci with evidence of interactions. Am J Hum Genet 69:1301–1313.
   PubMed Web of Science ®Google Scholar
• Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, Amore AM, 2007. Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease. Science 317:516–519.
   PubMed Web of Science ®Google Scholar
• Passier R, Zeng H, Frey N, Naya FJ, Nicol RL, McKinsey TA, 2000. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J Clin Invest 105:1395–1406.
   PubMed Web of Science ®Google Scholar
• Perissi V, Jepsen K, Glass CK, Rosenfeld MG. 2010. Deconstructing repression evolving models of co-repressor action. Nat Rev Genet 11:109–123.
   PubMed Web of Science ®Google Scholar
• Potthoff MJ, Wu H, Arnold MA, Shelton JM, Backs J, McAnally J, 2007. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J Clin Invest 117:2459–2467.
   PubMed Web of Science ®Google Scholar
• Pullinger CR, Eng C, Salen G, Shefer S, Batta AK, Erickson SK, 2002. Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 110:109–117.
   PubMed Web of Science ®Google Scholar
• Rajendran P, Ho E, Williams DE, Dashwood RH. 2011. Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. Clin Epigenetics 3:1–23.
   Google Scholar
• Rangwala SM, Lazar MA. 2004. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. Trends Pharmacol Sci 25:331–336.
   PubMed Web of Science ®Google Scholar
• Richards EJ, Elgin SCR. 2002. Epigenetic codes for heterochromatin formation and silencing: Rounding up the usual suspects. Cell 108:489–500.
   PubMed Web of Science ®Google Scholar
• Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. 2005. Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1. Nature 434:113–118.
   PubMed Web of Science ®Google Scholar
• Rodgers JT, Puigserver P. 2007. Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. Proc Natl Acad Sci USA 104:12861–12866.
   PubMed Web of Science ®Google Scholar
• Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, 2005. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310:1642–1646.
   PubMed Web of Science ®Google Scholar
• Sun Z, Singh N, Mullican SE, Everett LJ, Li L, Yuan L, 2011. Diet-induced lethality due to deletion of the Hdac3 gene in heart and skeletal muscle. J Biol Chem 286:33301–33309.
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Spiegelman BM. 2008. Fat and beyond: The diverse biology of PPARγ. Ann Rev Biochem 77:289–312.
   PubMed Web of Science ®Google Scholar
• Vaillant I, Paszkowski J. 2007. Role of histone and DNA methylation in gene regulation. Curr Opin Plant Biol 10:528–533.
   PubMed Web of Science ®Google Scholar
• Vega RB, Harrison BC, Meadows E, Roberts CR, Papst PJ, Olson EN, 2004. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol 24:8374–8385.
   PubMed Web of Science ®Google Scholar
• Viollet B, Guigas B, Leclerc J, Hebrard S, Lantier L, Mounier R, 2009. AMP-activated protein kinase in the regulation of hepatic energy metabolism: From physiology to therapeutic perspectives. Acta Physiol 196:81–98.
   PubMed Web of Science ®Google Scholar
• Wang L, Lee YK, Bundman D, Han Y, Thevananther S, Kim CS, 2002. Redundant pathways for negative feedback regulation of bile acid production. Dev Cell 2:721–731.
   PubMed Web of Science ®Google Scholar
• Weems JC, Griesel BA, Olson AL. 2012. Class II histone deacetylases downregulate GLUT4 transcription in response to increased cAMP signaling in cultured adipocytes and fasting mice. Diabetes 61:1404–1414.
   Google Scholar
• Xiang K, Wang Y, Zheng T, Jia W, Li J, Chen L, 2004. Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: Significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. Diabetes 53:228–234.
   PubMedGoogle Scholar
• Yamamoto H, Williams EG, Mouchiroud L, Cantó C, Fan W, Downes M, 2011. NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Cell 147:827–839.
   PubMedGoogle Scholar
• Yin L, Lazar MA. 2005. The orphan nuclear receptor Rev-erbα recruits the N-CoR/histone deacetylase3 corepressor to regulate the circadian Bmal1 gene. Mol Endocrinol 19:1452–1459.
   PubMedGoogle Scholar
• Yu S, Matsusue K, Kashireddy P, Cao WQ, Yeldandi V, Yeldandi AV, 2003. Adipocyte-specific gene expression and adipogenicsteatosis in the mouse liver due to peroxisome proliferator-activated receptor γ1 (PPARγ1) overexpression. J Biol Chem 278:498–505.
   PubMed Web of Science ®Google Scholar
• Yu C, Markan K, Temple KA, Deplewski D, Brady MJ, Cohen RN. 2005. The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis. J Biol Chem 280:13600–13605.
   PubMed Web of Science ®Google Scholar
• Zamir I, Harding HP, Atkins GB, Hörlein A, Glass CK, Rosenfeld MG, 1996. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol Cell Biol 16:5458–5465.
   PubMedGoogle Scholar
• Zhang YL, Hernandez-Ono A, Siri P, Weisberg S, Conlon D, Graham MJ, 2006. Aberrant hepatic expression of PPARγ2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. J Biol Chem 281:37603–37615.
   Google Scholar
• Zhao X, Sternsdorf T, Bolger TA, Evans RN, Yao TP, 2005. Regulation of MEF2 by histone deacetylase 4- and SIRT deacetylase mediated lysine modifications. Mol Cell Biol 25:8456–8464.
   PubMed Web of Science ®Google Scholar